|
KIF11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.739000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.650200E-01 |
| Normal-vs-Stage2 |
5.177500E-02 |
| Normal-vs-Stage3 |
5.929800E-01 |
| Normal-vs-Stage4 |
4.735800E-01 |
| Stage1-vs-Stage2 |
8.796100E-04 |
| Stage1-vs-Stage3 |
6.210000E-01 |
| Stage1-vs-Stage4 |
1.822970E-01 |
| Stage2-vs-Stage3 |
2.793900E-02 |
| Stage2-vs-Stage4 |
2.923200E-03 |
| Stage3-vs-Stage4 |
1.123600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.344000E-01 |
| Normal-vs-AfricanAmerican |
9.398000E-01 |
| Normal-vs-Asian |
4.288600E-01 |
| Caucasian-vs-AfricanAmerican |
9.707400E-01 |
| Caucasian-vs-Asian |
1.742550E-01 |
| AfricanAmerican-vs-Asian |
5.406400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.649600E-01 |
| Normal-vs-Female |
5.550600E-01 |
| Male-vs-Female |
2.602600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.380400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.589600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.095800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.497980E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.201900E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.685600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.945800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.813900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.561970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.761800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.231200E-01 |
| Classical-VS-Follicular |
3.3726000003842E-07 |
| Classical-VS-Other |
3.643400E-01 |
| Classical-VS-Normal |
8.997200E-01 |
| Tall-VS-Follicular |
1.543280E-03 |
| Tall-VS-Other |
2.159200E-01 |
| Tall-VS-Normal |
4.858000E-01 |
| Follicular-VS-Other |
4.890400E-01 |
| Follicular-VS-Normal |
2.639600E-02 |
| Other-VS-Normal |
3.083400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.091400E-01 |
| Normal-vs-N1 |
6.649800E-01 |
| N0-vs-N1 |
3.185600E-01 |
|
|
